Literature DB >> 2881290

Chronic neuroleptic effects on dopamine neuron activity: a model for predicting therapeutic efficacy and side effects?

A S Freeman, B S Bunney.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2881290     DOI： 10.1007/978-3-642-71288-3_26

Source DB:  PubMed          Journal:  Psychopharmacol Ser        ISSN： 0931-6795


× No keyword cloud information.
  3 in total

Review 1.  Neuromodulation for the treatment of eating disorders and obesity.

Authors:  Darrin J Lee; Gavin J B Elias; Andres M Lozano
Journal:  Ther Adv Psychopharmacol       Date:  2017-12-08

Review 2.  Abnormal striatal dopamine transmission in schizophrenia.

Authors:  Jerome Brunelin; Shirley Fecteau; Marie-Françoise Suaud-Chagny
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

3.  The novel atypical antipsychotic cariprazine demonstrates dopamine D2 receptor-dependent partial agonist actions on rat mesencephalic dopamine neuronal activity.

Authors:  Sarah Delcourte; Charles R Ashby; Renaud Rovera; Béla Kiss; Nika Adham; Bence Farkas; Nasser Haddjeri
Journal:  CNS Neurosci Ther       Date:  2018-05-04       Impact factor: 5.243
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.